MagForce AG Share Price Xetra

Equities

MF6

DE000A0HGQF5

Biotechnology & Medical Research

End-of-day quote Xetra 23:00:00 10/08/2022 BST 5-day change 1st Jan Change
0.1165 EUR -.--% Intraday chart for MagForce AG -.--% -.--%

Financials

Sales 2020 1.5M 1.61M 129M Sales 2021 1.08M 1.15M 92.23M Capitalization 61.05K 65.28K 5.23M
Net income 2020 14M 14.97M 1.2B Net income 2021 -10M -10.69M -856M EV / Sales 2020 * -
Net cash position 2020 * - 0 0 Net cash position 2021 * - 0 0 EV / Sales 2021 * -
P/E ratio 2020 *
-
P/E ratio 2021 *
-
Employees 33
Yield 2020 *
-
Yield 2021 *
-
Free-Float 74.32%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.11
Extreme 0.11
4.32
5 years
0.11
Extreme 0.11
5.72
10 years
0.11
Extreme 0.11
8.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 84 31/08/13
Director of Finance/CFO 52 02/05/12
Members of the board TitleAgeSince
Chairman 52 11/08/21
Director/Board Member 43 -
Director/Board Member - -
More insiders
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
More about the company

Chiffre d''affaires - Rate of surprise